Narayana Hrudayalaya Ltd
NSE: NH BSE: 539551Healthcare
Narayana Hrudayalaya Ltd is engaged in providing economical healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations.[1]
₹1,862
52W: ₹1564 — ₹2372
PE 77 · Book ₹114 · +1533% vs bookMarket Cap₹38,046 Cr
Stock P/E77Price to Earnings
ROCE19.4%Return on Capital
ROE21%Return on Equity
Div. Yield0.24%Face Value ₹10
Strengths
- +Company has delivered good profit growth of 43.4% CAGR over last 5 years
- +Company has been maintaining a healthy dividend payout of 19.9%
Weaknesses
- −Stock is trading at 16.1 times its book value
- −The company has delivered a poor sales growth of 9.90% over past five years.
Shareholding Pattern
Promoters63.27%
FIIs9.98%
DIIs9.14%
Public16.98%
| Category | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 63.85% | 63.85% | 63.85% | 63.85% | 63.85% | 63.85% | 63.27%▼0.6 | 63.27% |
| FIIs | 10.01% | 9.69%▼0.3 | 9.45%▼0.2 | 9.66%▲0.2 | 10.46%▲0.8 | 10.49%▲0.0 | 11.1%▲0.6 | 9.98%▼1.1 |
| DIIs | 8.22% | 7.9%▼0.3 | 8.68%▲0.8 | 8.52%▼0.2 | 8.09%▼0.4 | 7.76%▼0.3 | 7.91%▲0.2 | 9.14%▲1.2 |
| Public | 17.29% | 17.94%▲0.7 | 17.39%▼0.6 | 17.34%▼0.1 | 16.98%▼0.4 | 17.29%▲0.3 | 17.09%▼0.2 | 16.98%▼0.1 |
Financial Statements
| Metric | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 852 | 771 | 846 | 872 | 934 | 865 | 919 | 943 | 1,019 | 969 |
| Expenses | 688 | 633 | 690 | 715 | 752 | 708 | 743 | 764 | 790 | 764 |
| Operating Profit | 164 | 138 | 156 | 157 | 183 | 157 | 176 | 179 | 229 | 205 |
| OPM % | 19% | 18% | 18% | 18% | 20% | 18% | 19% | 19% | 22% | 21% |
| Net Profit | 109 | 79 | 158 | 86 | 106 | 79 | 160 | 87 | 138 | 76 |
| EPS ₹ | 5.33 | 3.85 | 7.74 | 4.23 | 5.16 | 3.88 | 7.83 | 4.28 | 6.75 | 3.71 |
AI Insights
Revenue Trend
TTM revenue at ₹3,850Cr, up 7.2% YoY. OPM at 20%.
Debt Position
Borrowings at ₹1,598Cr. Debt-to-equity ratio: 0.76x. Moderate leverage.
Capex Cycle
CWIP at ₹95Cr (4% of fixed assets). Moderate ongoing capital expenditure.
Institutional Flow
DIIs: 9.14% (-2.81pp change). FIIs: 9.98% (-1.12pp change). Promoters hold 63.27%.
Margin & Efficiency
ROCE improving from 9% (Mar 2014) to 19% (Mar 2025). Working capital days: -33.
Valuation
PE 77x with 19.4% ROCE. Price is 1533% above book value of ₹114. Dividend yield: 0.24%.
Recent Announcements
- Announcement under Regulation 30 (LODR)-Newspaper Publication 2 May - Newspaper publication of Form No. NCLT 3A (Advertisement detailing petition) in the matter of scheme of Arrangement between NH Integrated Care Private Limited (Demerged company) …
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 23 Apr - Narayana Hrudayalaya files initial disclosure as a SEBI Large Corporate with Rs. 1,838.54 crore borrowing.
- Revised Scrutinizer Report Of General Meeting Of Equity Shareholders Of The Company Held On April 02 2026 Pursuant To Order Dated Feb 13 2026 By The Hon''ble NCLT, Bengaluru Along With Scrutinizer Report Of Secured And Unsecured Creditors Of Company. 6 Apr - Revised scrutinizer report filed for April 2 vote; shareholders and creditors approved the NH Integrated Care demerger scheme.
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 6 Apr
- Submission Of Voting Results And Scrutinizer''s Report For The General Meeting Of The Equity Shareholders, Secured Creditors, Unsecured Creditors Of The Company Held On April 02, 2026 Convened Pursuant To Order Dated Feb 13 2026 By The Hon''ble NCLT, Bengaluru 3 Apr - Voting results show approval of scheme between NH Integrated Care and Narayana Hrudayalaya on April 2, 2026.
- Financial Year 2025 from bse
- Financial Year 2024 from bse
- Financial Year 2023 from bse